

Laos Daxiong Pharmaceutical Apalutamide APADX60mg120 tablets
Indications: Suitable for the treatment of metastatic castration-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer in the following patients
Metastatic prostate cancer
FDA approved
Authoritative certification
Indications:
60mg*120 tablets/box
Suitable for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of metastasis.
Recommended dose: {For reference only, follow the doctor's advice}
The recommended dose is 240mg (4 tablets), taken orally once a day. It can be taken alone or with food. The whole tablet should be swallowed with water. If you miss a dose, you should take the medicine as soon as possible on the same day, and take the medicine as planned the next day. Do not take extra to make up for the missed dose.



